Get started
Benitec Biopharma Inc.Benitec Biopharma Inc.Benitec Biopharma Inc.

Benitec Biopharma Inc.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFs
Full chart
Full chart

Compare with Benitec Biopharma Inc.



Key stats


Market capitalization
‪305.22 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.09 USD
Net income (FY)
‪−45.55 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪33.99 M‬
Beta (1Y)
2.20

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
24
Change (1Y)
+5+26.32%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.90 M‬ USD

Company info


Sector
Health Technology
Industry
Biotechnology
CEO
Jerel A. Banks
Website
benitec.com
Headquarters
Hayward
Founded
1995
IPO date
Jul 11, 2012
ISIN
US08205P2092
CUSIP
08205P209
FIGI
BBG00R712L56
Identifiers
ISIN US08205P2092
CFI code
ESVUFR
Benitec Biopharma, Inc. is a development-stage biotechnology company, which engages in the advancement of novel genetic medicines. The firm's proprietary platforms include DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration. It is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy and Chronic Hepatitis B. The company was founded in 1995 and is headquartered in Hayward, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral

Analyst rating


An aggregate view of professional's ratings.
Neutral
Neutral
Neutral

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


PINK
Simplify Health Care ETF
Weight3.04%
Market value‪9.72 M‬
IWC
iShares Microcap ETF
Weight0.04%
Market value‪592.63 K‬
GNOM
Global X Genomics & Biotechnology UCITS ETF
Weight0.22%
Market value‪298.96 K‬
VTWV
Vanguard Russell 2000 Value ETF
Weight0.02%
Market value‪226.36 K‬
GNOM
Global X Genomics & Biotechnology ETF
Weight0.22%
Market value‪213.22 K‬
IBRN
iShares Neuroscience and Healthcare ETF
Weight0.46%
Market value‪28.80 K‬

Explore more ETFs 

Frequently asked questions


The current price of BNTC is 8.87 USD — it has increased by 1.37% in the past 24 hours. Watch Benitec Biopharma Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Benitec Biopharma Inc. stocks are traded under the ticker BNTC.
BNTC stock has fallen by −8.65% compared to the previous week, the month change is a −30.05% fall, over the last year Benitec Biopharma Inc. has showed a −36.91% decrease.
We've gathered analysts' opinions on Benitec Biopharma Inc. future price: according to them, BNTC price has a max estimate of 32.00 USD and a min estimate of 17.00 USD. Watch BNTC chart and read a more detailed Benitec Biopharma Inc. stock forecast: see what analysts think of Benitec Biopharma Inc. and suggest that you do with its stocks.
BNTC reached its all-time high on Aug 5, 2015 with the price of 2,409.01 USD, and its all-time low was 1.86 USD and was reached on Aug 9, 2023. View more price dynamics on BNTC chart.
See other stocks reaching their highest and lowest prices.
BNTC stock is 3.67% volatile and has beta coefficient of 2.20. Track Benitec Biopharma Inc. stock price on the chart and check out the list of the most volatile stocks — is Benitec Biopharma Inc. there?
Today Benitec Biopharma Inc. has the market capitalization of ‪305.22 M‬, it has decreased by −10.00% over the last week.
Yes, you can track Benitec Biopharma Inc. financials in yearly and quarterly reports right on TradingView.
Benitec Biopharma Inc. is going to release the next earnings report on Nov 16, 2026. Keep track of upcoming events with our Earnings Calendar.
BNTC earnings for the last quarter are −0.26 USD per share, whereas the estimation was −0.26 USD resulting in a 1.62% surprise. The estimated earnings for the next quarter are −0.27 USD per share. See more details about Benitec Biopharma Inc. earnings.
Benitec Biopharma Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
BNTC net income for the last quarter is ‪−12.81 M‬ USD, while the quarter before that showed ‪−11.94 M‬ USD of net income which accounts for 0.00% change. Track more Benitec Biopharma Inc. financial stats to get the full picture.
No, BNTC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 10, 2026, the company has 24 employees. See our rating of the largest employees — is Benitec Biopharma Inc. on this list?
Like other stocks, BNTC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Benitec Biopharma Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Benitec Biopharma Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Benitec Biopharma Inc. stock shows the sell signal. See more of Benitec Biopharma Inc. technicals for a more comprehensive analysis.